Pharmafile Logo

The Clinical Trial Company

The Clinical Trial Company (TCTC) targets medium size clinical trials and novel products which lack a classical road map to the market.
Large CROs prioritise studies from the big pharma companies, for good business reasons. However, this approach sometimes disadvantages their SME clients who are equally keen to complete their clinical trials quickly. TCTC are experts in advanced therapies, such as cell and gene therapies, as well as orphan drug and biologics.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.

View Profile

Uniphar

Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.

View Profile

Company Details

Mere View Barn, Park Lane, Pickmere, Knutsford, WA16 0LG, UK
+44 1565 733 772

 Latest Content from PMHub 

How will Sustainability and Transformation Plans (STPs) change the NHS commissioning landscape?

Sue Thomas and Paul Midgley, of Wilmington Healthcare, take a look at new commissioning structures and what they mean for pharma

eyeforpharma Barcelona 2017 highlights: Industry at the brink of transformation

Hear what Anthill's delegates reported back from the biggest eyeforpharma Barcelona yet.

Pharma China Annual Forum 2017

We are delighted to be presenting a paper at the Pharma China Annual Forum on 14th April 2017 in Shanghai, China.

Healthcare Market Research in the Gulf: 3 lessons I’ve learned

A few key considerations for conducting healthcare market research in the Gulf

Case study: Multiple Sclerosis new medical device research

Our client wanted to find out how best to develop an implantable delivery device technology with add-on services in the Multiple Sclerosis market. We were tasked with finding out whether such a...

Getting the most out of your agency – a guide to developing a dynamic and rewarding relationship with your agency partner

A high proportion of pharma and biotech marketing budget is spent on medical communications agencies. In fact, over the years the size of this service industry has grown enormously and is...

New report shows Traumatic Brain Injury (TBI) is a major threat to older people

A report by healthcare intelligence provider Wilmington Healthcare and the charity, United Kingdom Acquired Brain Injury Forum (UKABIF), shows that many hospital admissions in England for Traumatic Brain Injury (TBI)...

Bring some #LucidLife to your medical education programmes

Meet Madeleine, an Account Director.Madeleine understands the importance of improving patient outcomes and has played a pivotal part in developing many of our award-winning behaviour-change programmes.Our people are our biggest...

Empowering nurses to transform patient care

As Sustainability and Transformation Plans (STPs) turn to action across England, Page & Page’s Communications Director Cori Hollenbach explores whether healthcare companies are considering the influence nurses can have on...

Patient Centricity: Turning Rhetoric into Reality

Live webinar: Thursday 30th March 10:00 EDT / 15:00 BST / 16:00 CEST